Intranasal Inhalations of M2 Macrophage Soluble Factors in Children With Developmental Speech Disorders

Clinical trial NCT04689282 · COMPLETED

Trial details

NCT number: NCT04689282
Sponsor: Russian Academy of Medical Sciences
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Language Delay Language; Developmental Disorder, Expressive Language; Developmental Disorder, Receptive Autism Spectrum Disorder Attention Deficit-Hyperactivity Disorder Speech Disorders in Children

Start date: 2020-02-01
Primary completion: 2021-09-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.